Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 5/2020

28.07.2020 | Original Article

Evaluating Focal 18F-FDG Uptake in Thyroid Gland with Radiomics

verfasst von: Ayşegül Aksu, Nazlı Pınar Karahan Şen, Emine Acar, Gamze Çapa Kaya

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate the ability of 18F-FDG PET/CT texture analysis to predict the exact pathological outcome of thyroid incidentalomas.

Methods

18F-FDG PET/CT images between March 2010 and September 2018 were retrospectively reviewed in patients with focal 18F-FDG uptake in the thyroid gland and who underwent fine needle aspiration biopsy from this area. The focal uptake in the thyroid gland was drawn in 3D with 40% SUVmax threshold. Features were extracted from volume of interest (VOI) using the LIFEx package. The features obtained were compared in benign and malignant groups, and statistically significant variables were evaluated by receiver operating curve (ROC) analysis. The correlation between the variables with area under curve (AUC) value over 0.7 was examined; variables with correlation coefficient less than 0.6 were evaluated with machine learning algorithms.

Results

Sixty patients (70% train set, 30% test set) were included in the study. In univariate analysis, a statistically significant difference was observed in 6 conventional parameters, 5 first-, and 16 second-order features between benign and malignant groups in train set (p < 0.05). The feature with the highest benign-malignant discriminating power was GLRLMRLNU (AUC:0.827). AUC value of SUVmax was calculated as 0.758. GLRLMRLNU and SUVmax were evaluated to build a model to predict the exact pathology outcome. Random forest algorithm showed the best accuracy and AUC (78.6% and 0.849, respectively).

Conclusion

In the differentiation of benign-malignant thyroid incidentalomas, GLRLMRLNU and SUVmax combination may be more useful than SUVmax to predict the outcome.
Literatur
1.
Zurück zum Zitat Thuillier P, Roudaut N, Crouzeix G, Cavarec M, Robin P, Abgral R, et al. Malignancy rate of focal thyroid incidentaloma detected by FDG PET–CT: results of a prospective cohort study. Endocr Connect. 2017;6:413–21.CrossRef Thuillier P, Roudaut N, Crouzeix G, Cavarec M, Robin P, Abgral R, et al. Malignancy rate of focal thyroid incidentaloma detected by FDG PET–CT: results of a prospective cohort study. Endocr Connect. 2017;6:413–21.CrossRef
2.
Zurück zum Zitat Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609–15.PubMed Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609–15.PubMed
3.
Zurück zum Zitat Pagano L, Sama MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol. 2011;75:528–34.CrossRef Pagano L, Sama MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol. 2011;75:528–34.CrossRef
4.
Zurück zum Zitat Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012;97:3866–75.CrossRef Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012;97:3866–75.CrossRef
5.
Zurück zum Zitat Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 2009;30:742–8.CrossRef Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 2009;30:742–8.CrossRef
6.
Zurück zum Zitat Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid. 2012;22:918–25.CrossRef Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid. 2012;22:918–25.CrossRef
7.
Zurück zum Zitat Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941–6.CrossRef Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941–6.CrossRef
8.
Zurück zum Zitat Hagenimana N, Dallaire J, Vallée É, Belzile M. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation. J Otolaryngol Head Neck Surg. 2017:46–22. Hagenimana N, Dallaire J, Vallée É, Belzile M. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation. J Otolaryngol Head Neck Surg. 2017:46–22.
9.
Zurück zum Zitat Kim JM, Ryu JS, Kim TY, Kim WB, Kwon GY, Gong G, et al. 18F-Fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab. 2007;92:1630–4.CrossRef Kim JM, Ryu JS, Kim TY, Kim WB, Kwon GY, Gong G, et al. 18F-Fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab. 2007;92:1630–4.CrossRef
10.
Zurück zum Zitat Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol. 2007;14:239–47.CrossRef Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol. 2007;14:239–47.CrossRef
11.
Zurück zum Zitat Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Nucl Med Commun. 2013;34:868–76.CrossRef Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Nucl Med Commun. 2013;34:868–76.CrossRef
12.
Zurück zum Zitat Shi H, Yuan Z, Yuan Z, Yang C, Zhang J, Shou Y, et al. Diagnostic value of volume-based fluorine-18-fluorodeoxyglucose PET/CT parameters for characterizing thyroid incidentaloma. Korean J Radiol. 2018;19:342–51.CrossRef Shi H, Yuan Z, Yuan Z, Yang C, Zhang J, Shou Y, et al. Diagnostic value of volume-based fluorine-18-fluorodeoxyglucose PET/CT parameters for characterizing thyroid incidentaloma. Korean J Radiol. 2018;19:342–51.CrossRef
13.
Zurück zum Zitat Parvez A, Tau N, Hussey D, Maganti M, Metser U, et al. 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival. Ann Nucl Med. 2018;32:410–6.CrossRef Parvez A, Tau N, Hussey D, Maganti M, Metser U, et al. 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival. Ann Nucl Med. 2018;32:410–6.CrossRef
14.
Zurück zum Zitat Zhou L, Zhang Z, Chen YC, Zhao ZY, Yin XD, Jiang HB. A deep learning-based radiomics model for differentiating benign and malignant renal tumors. Transl Oncol. 2019;12:292–300.CrossRef Zhou L, Zhang Z, Chen YC, Zhao ZY, Yin XD, Jiang HB. A deep learning-based radiomics model for differentiating benign and malignant renal tumors. Transl Oncol. 2019;12:292–300.CrossRef
15.
Zurück zum Zitat Mao N, Yin P, Wang Q, Liu M, Dong J, Zhang X, et al. Added value of radiomics on mammography for breast cancer diagnosis: a feasibility study. J Am Coll Radiol. 2019;16:485–91.CrossRef Mao N, Yin P, Wang Q, Liu M, Dong J, Zhang X, et al. Added value of radiomics on mammography for breast cancer diagnosis: a feasibility study. J Am Coll Radiol. 2019;16:485–91.CrossRef
16.
Zurück zum Zitat Abdollahi H, Mofid B, Shiri I, Razzaghdoust A, Saadipoor A, Mahdavi A, et al. Machine-learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer. Radiol Med. 2019;124:555–67.CrossRef Abdollahi H, Mofid B, Shiri I, Razzaghdoust A, Saadipoor A, Mahdavi A, et al. Machine-learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer. Radiol Med. 2019;124:555–67.CrossRef
17.
Zurück zum Zitat Yang L, Yang J, Zhou X, Huang L, Zhao W, Wang T, et al. Development of a radiomics nomogram on the 2D and 3D CT features to predict the survival of non-small cancer patients. Eur Radiol. 2019;29:2196–206.CrossRef Yang L, Yang J, Zhou X, Huang L, Zhao W, Wang T, et al. Development of a radiomics nomogram on the 2D and 3D CT features to predict the survival of non-small cancer patients. Eur Radiol. 2019;29:2196–206.CrossRef
18.
Zurück zum Zitat Zheng BH, Liu LZ, Zhang ZZ, Shi JY, Dong LQ, Tian LY, et al. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patient. BMC Cancer. 2018;18:1148.CrossRef Zheng BH, Liu LZ, Zhang ZZ, Shi JY, Dong LQ, Tian LY, et al. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patient. BMC Cancer. 2018;18:1148.CrossRef
19.
Zurück zum Zitat Sollini M, Cozzi L, Pepe G, Antunovic L, Lania A, Di Tommaso L, et al. [18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results. Eur J Hybrid Imaging. 2017;1:3.CrossRef Sollini M, Cozzi L, Pepe G, Antunovic L, Lania A, Di Tommaso L, et al. [18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results. Eur J Hybrid Imaging. 2017;1:3.CrossRef
20.
Zurück zum Zitat Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786–9.CrossRef Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786–9.CrossRef
21.
Zurück zum Zitat Ouyang FS, Guo BL, Zhang B, Dong YH, Zhang L, Mo XK, et al. Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma. Oncotarget. 2017;24:74869–79.CrossRef Ouyang FS, Guo BL, Zhang B, Dong YH, Zhang L, Mo XK, et al. Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma. Oncotarget. 2017;24:74869–79.CrossRef
22.
Zurück zum Zitat Huang Z, Zhang W, He D, Cui X, Tian S, Yin H, et al. Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer: study protocol clinical trial (SPIRIT Compliant). Medicine (Baltimore). 2020;99:e19428.CrossRef Huang Z, Zhang W, He D, Cui X, Tian S, Yin H, et al. Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer: study protocol clinical trial (SPIRIT Compliant). Medicine (Baltimore). 2020;99:e19428.CrossRef
23.
Zurück zum Zitat Schernberg A, Reuze S, Orlhac F, et al. A score combining baseline neutrophilia and primary tumor SUV peak measured from FDG PET is associated with outcome in locally advanced cervical cancer. Eur J Nucl Med Mol Imaging. 2018;45:187–95.CrossRef Schernberg A, Reuze S, Orlhac F, et al. A score combining baseline neutrophilia and primary tumor SUV peak measured from FDG PET is associated with outcome in locally advanced cervical cancer. Eur J Nucl Med Mol Imaging. 2018;45:187–95.CrossRef
24.
Zurück zum Zitat Boughdad S, Nioche C, Orlhac F, et al. Influence of age on radiomic features in 18 F-FDG PET in normal breast tissue and in breast cancer tumors. Oncotarget. 2018;20(9):30855–68.CrossRef Boughdad S, Nioche C, Orlhac F, et al. Influence of age on radiomic features in 18 F-FDG PET in normal breast tissue and in breast cancer tumors. Oncotarget. 2018;20(9):30855–68.CrossRef
25.
Zurück zum Zitat Zhou H, Jiang J, Lu J, Wang M, Zhang H, Zuo C. Dual-model radiomic biomarkers predict development of mild cognitive impairment progression to Alzheimer’s disease. Front Neurosci. 2019;12:1045.CrossRef Zhou H, Jiang J, Lu J, Wang M, Zhang H, Zuo C. Dual-model radiomic biomarkers predict development of mild cognitive impairment progression to Alzheimer’s disease. Front Neurosci. 2019;12:1045.CrossRef
26.
Zurück zum Zitat Chan YH. Bioistatistics 104: correlation analysis. Singap Med J. 2003;44:614–9. Chan YH. Bioistatistics 104: correlation analysis. Singap Med J. 2003;44:614–9.
27.
Zurück zum Zitat Sharma C. Diagnostic accuracy of fine needle aspiration cytology of thyroid and evaluation of discordant cases. J Egypt Natl Canc Inst. 2015;27:147–53.CrossRef Sharma C. Diagnostic accuracy of fine needle aspiration cytology of thyroid and evaluation of discordant cases. J Egypt Natl Canc Inst. 2015;27:147–53.CrossRef
28.
Zurück zum Zitat Machała E, Sopiński J, Iavorska I, Kołomecki K. Correlation of fine needle aspiration cytology of thyroid gland with histopathological results. Pol Przegl Chir. 2018;21(90):1–5.CrossRef Machała E, Sopiński J, Iavorska I, Kołomecki K. Correlation of fine needle aspiration cytology of thyroid gland with histopathological results. Pol Przegl Chir. 2018;21(90):1–5.CrossRef
29.
Zurück zum Zitat Sukumaran R, Kattoor J, Pillai KR, Ramadas PT, Nayak N, Somanathan T, et al. Fine needle aspiration cytology of thyroid lesions and its correlation with histopathology in a series of 248 patients. Indian J Surg Oncol. 2014;5:237–41.CrossRef Sukumaran R, Kattoor J, Pillai KR, Ramadas PT, Nayak N, Somanathan T, et al. Fine needle aspiration cytology of thyroid lesions and its correlation with histopathology in a series of 248 patients. Indian J Surg Oncol. 2014;5:237–41.CrossRef
30.
Zurück zum Zitat Cook GJR, Azad G, Owczarczyk K. Challenges and promises of PET radiomic. Int J Radiat Oncol Biol Phys. 2018;15(102):1083–9.CrossRef Cook GJR, Azad G, Owczarczyk K. Challenges and promises of PET radiomic. Int J Radiat Oncol Biol Phys. 2018;15(102):1083–9.CrossRef
Metadaten
Titel
Evaluating Focal 18F-FDG Uptake in Thyroid Gland with Radiomics
verfasst von
Ayşegül Aksu
Nazlı Pınar Karahan Şen
Emine Acar
Gamze Çapa Kaya
Publikationsdatum
28.07.2020
Verlag
Springer Singapore
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 5/2020
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-020-00659-2

Weitere Artikel der Ausgabe 5/2020

Nuclear Medicine and Molecular Imaging 5/2020 Zur Ausgabe